NUCLEOSIDE TRANSPORTERS: CNTs AND ENTs - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 193

34. Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M. 2001.
Complex regulation of nucleoside transporter expression in epithelial and immune system
cells. Mol Membr Biol 18(1):81-85.
35. Li JY, Boado RJ, Pardridge WM. 2001. Cloned blood-brain barrier adenosine transporter
is identical to the rat concentrative Na + nucleoside cotransporter CNT2. J Cereb Blood
Flow Metab 21(8):929-936.
36. Redzic ZB, Biringer J, Barnes K, Baldwin SA, Al-Sarraf H, Nicola PA, Young JD, Cass
CE, Barrand MA, Hladky SB. 2005. Polarized distribution of nucleoside transporters
in rat brain endothelial and choroid plexus epithelial cells. J Neurochem 94(5):1420-
1426.
37. Gutierrez MM, Brett CM, Ott RJ, Hui AC, Giacomini KM. 1992. Nucleoside transport in
brush border membrane vesicles from human kidney. Biochim Biophys Acta 1105(1):1-9.
38. Patil SD, Ngo LY, Unadkat JD. 2000. Structure-inhibitory profiles of nucleosides for the
human intestinal N1 and N2 Na + -nucleoside transporters. Cancer Chemother Pharmacol
46(5):394-402.
39. Schaner ME, Wang J, Zevin S, Gerstin KM, Giacomini KM. 1997. Transient expression
of a purine-selective nucleoside transporter (SPNTint) in a human cell line (HeLa). Pharm
Res 14(10):1316-1321.
40. Schaner ME, Wang J, Zhang L, Su SF, Gerstin KM, Giacomini KM. 1999. Func-
tional characterization of a human purine-selective, Na + -dependent nucleoside trans-
porter (hSPNT1) in a mammalian expression system. J Pharmacol Exp Ther 289(3):1487-
1491.
41. Patil SD, Ngo LY, Glue P, Unadkat JD. 1998. Intestinal absorption of ribavirin is preferen-
tially mediated by the Na + -nucleoside purine (N1) transporter. Pharm Res 15(6):950-952.
42. Owen RP, Gray JH, Taylor TR, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke
D, Ferrin TE, Giacomini KM. 2005. Genetic analysis and functional characterization of
polymorphisms in the human concentrative nucleoside transporter, CNT2. Pharmacogenet
Genom 15(2):83-90.
43. King KM, Damaraju VL, Vickers MF, Yao SY, Lang T, Tackaberry TE, Mowles DA,
Ng AM, Young JD, Cass CE. 2006. A comparison of the transportability, and its role in
cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside
transporters produced in three model expression systems. Mol Pharmacol 69(1):346-353.
44. Lang TT, Selner M, Young JD, Cass CE. 2001. Acquisition of human concentrative nucle-
oside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine
nucleosides in drug-resistant leukemia cells. Mol Pharmacol 60(5):1143-1152.
45. Gerstin KM, Dresser MJ, Giacomini KM. 2002. Specificity of human and rat orthologs of
the concentrative nucleoside transporter, SPNT. Am J Physiol Renal Physiol 283(2):F344-
F349.
46. Li JY, Boado RJ, Pardridge WM. 2001. Differential kinetics of transport of 2 ,3 -
dideoxyinosine and adenosine via concentrative Na + nucleoside transporter CNT2 cloned
from rat blood-brain barrier. J Pharmacol Exp Ther 299(2):735-740.
47. Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles
DA, Carpenter P, Chen XZ, et al. 2001. Molecular identification and characterization of
novel human and mouse concentrative Na + -nucleoside cotransporter proteins (hCNT3
and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol
Chem 276(4):2914-2927.